• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于增强 CT 影像组学预测胰腺导管腺癌淋巴结转移的初步研究

Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.

机构信息

Department of Radiology, Southwest Hospital, Army Medical University, Chongqing, 400038, China.

Department of Radiology, Sichuan Science City Hospital, Mianyang, Sichuan, China.

出版信息

Cancer Imaging. 2020 Jan 30;20(1):12. doi: 10.1186/s40644-020-0288-3.

DOI:10.1186/s40644-020-0288-3
PMID:32000852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6993448/
Abstract

BACKGROUND

We developed a computational model integrating clinical data and imaging features extracted from contrast-enhanced computed tomography (CECT) images, to predict lymph node (LN) metastasis in patients with pancreatic ductal adenocarcinoma (PDAC).

METHODS

This retrospective study included 159 patients with PDAC (118 in the primary cohort and 41 in the validation cohort) who underwent preoperative contrast-enhanced computed tomography examination between 2012 and 2015. All patients underwent surgery and lymph node status was determined. A total of 2041 radiomics features were extracted from venous phase images in the primary cohort, and optimal features were extracted to construct a radiomics signature. A combined prediction model was built by incorporating the radiomics signature and clinical characteristics selected by using multivariable logistic regression. Clinical prediction models were generated and used to evaluate both cohorts.

RESULTS

Fifteen features were selected for constructing the radiomics signature based on the primary cohort. The combined prediction model for identifying preoperative lymph node metastasis reached a better discrimination power than the clinical prediction model, with an area under the curve of 0.944 vs. 0.666 in the primary cohort, and 0.912 vs. 0.713 in the validation cohort.

CONCLUSIONS

This pilot study demonstrated that a noninvasive radiomics signature extracted from contrast-enhanced computed tomography imaging can be conveniently used for preoperative prediction of lymph node metastasis in patients with PDAC.

摘要

背景

我们开发了一种计算模型,该模型整合了来自增强型计算机断层扫描(CECT)图像的临床数据和影像学特征,以预测胰腺导管腺癌(PDAC)患者的淋巴结(LN)转移。

方法

本回顾性研究纳入了 159 例 PDAC 患者(118 例来自初级队列,41 例来自验证队列),这些患者于 2012 年至 2015 年间接受了术前增强型计算机断层扫描检查。所有患者均接受了手术,且淋巴结状态得到了确定。在初级队列的静脉相图像中提取了总共 2041 个放射组学特征,并提取了最佳特征来构建放射组学特征。通过使用多变量逻辑回归选择放射组学特征和临床特征,构建了一个联合预测模型。生成了临床预测模型并用于评估两个队列。

结果

基于初级队列,选择了 15 个特征来构建放射组学特征。用于识别术前淋巴结转移的联合预测模型的鉴别能力优于临床预测模型,在初级队列中的曲线下面积为 0.944 对 0.666,在验证队列中的曲线下面积为 0.912 对 0.713。

结论

这项初步研究表明,从增强型计算机断层扫描成像中提取的非侵入性放射组学特征可方便地用于预测 PDAC 患者的术前淋巴结转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/2d771aaf8a00/40644_2020_288_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/1d5255a5516b/40644_2020_288_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/888084a5dff2/40644_2020_288_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/90d6e461a05d/40644_2020_288_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/26685d8daf22/40644_2020_288_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/2d771aaf8a00/40644_2020_288_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/1d5255a5516b/40644_2020_288_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/888084a5dff2/40644_2020_288_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/90d6e461a05d/40644_2020_288_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/26685d8daf22/40644_2020_288_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e764/6993448/2d771aaf8a00/40644_2020_288_Fig5_HTML.jpg

相似文献

1
Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study.基于增强 CT 影像组学预测胰腺导管腺癌淋巴结转移的初步研究
Cancer Imaging. 2020 Jan 30;20(1):12. doi: 10.1186/s40644-020-0288-3.
2
Applying a radiomics-based strategy to preoperatively predict lymph node metastasis in the resectable pancreatic ductal adenocarcinoma.应用基于放射组学的策略术前预测可切除胰腺导管腺癌的淋巴结转移。
J Xray Sci Technol. 2020;28(6):1113-1121. doi: 10.3233/XST-200730.
3
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.基于影像组学的列线图模型预测胰腺导管腺癌淋巴结转移
Cancer Imaging. 2022 Jan 6;22(1):4. doi: 10.1186/s40644-021-00443-1.
4
Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study.基于 CT 影像组学构建用于预测胰腺导管腺癌 Ki-67 指数的列线图:一项多中心回顾性研究。
Eur Radiol. 2024 May;34(5):2934-2943. doi: 10.1007/s00330-023-10393-w. Epub 2023 Nov 8.
5
Comparison of MRI and CT-based radiomics for preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.基于 MRI 和 CT 的影像组学在胰导管腺癌术前预测淋巴结转移中的比较。
Acta Radiol. 2023 Jul;64(7):2221-2228. doi: 10.1177/02841851221142552. Epub 2022 Dec 6.
6
Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes.CT 胆管癌:一种基于放射组学的模型,用于预测淋巴结转移和生存结局。
Radiology. 2019 Jan;290(1):90-98. doi: 10.1148/radiol.2018181408. Epub 2018 Oct 16.
7
Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.应用增强 CT 和 CA19-9 对 R0 切除术后胰腺导管腺癌患者无病生存的术前预测。
Eur Radiol. 2024 Jan;34(1):509-524. doi: 10.1007/s00330-023-09980-8. Epub 2023 Jul 28.
8
Deep learning radiomics of dual-energy computed tomography for predicting lymph node metastases of pancreatic ductal adenocarcinoma.用于预测胰腺导管腺癌淋巴结转移的双能计算机断层扫描深度学习影像组学
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1187-1199. doi: 10.1007/s00259-021-05573-z. Epub 2021 Oct 15.
9
Relationship Between Radiomics and Risk of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma.基于影像组学的胰腺导管腺癌淋巴结转移风险预测模型。
Pancreas. 2019 Oct;48(9):1195-1203. doi: 10.1097/MPA.0000000000001404.
10
A radiomics-based model for prediction of lymph node metastasis in gastric cancer.基于放射组学的胃癌淋巴结转移预测模型。
Eur J Radiol. 2020 Aug;129:109069. doi: 10.1016/j.ejrad.2020.109069. Epub 2020 May 18.

引用本文的文献

1
Dual-layer spectral detector CT: a non-invasive tool for simultaneously predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma.双层光谱探测器CT:一种用于同时预测胰腺导管腺癌中Ki-67增殖状态和p53突变的非侵入性工具。
Abdom Radiol (NY). 2025 Jul 14. doi: 10.1007/s00261-025-05115-3.
2
A radiomics-based model for predicting lymph nodes metastasis of pancreatic ductal adenocarcinoma: a multicenter study.一种基于影像组学的预测胰腺导管腺癌淋巴结转移的模型:一项多中心研究。
Insights Imaging. 2025 Jun 27;16(1):141. doi: 10.1186/s13244-025-02025-2.
3
Personalized Medical Approach in Gastrointestinal Surgical Oncology: Current Trends and Future Perspectives.

本文引用的文献

1
Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.验证美国癌症联合委员会第 8 版胰腺导管腺癌分期系统。
Eur J Surg Oncol. 2019 Nov;45(11):2159-2165. doi: 10.1016/j.ejso.2019.06.002. Epub 2019 Jun 3.
2
The diagnostic accuracy of CT and MRI for the detection of lymph node metastases in gallbladder cancer: A systematic review and meta-analysis.CT 和 MRI 诊断胆囊癌淋巴结转移的准确性:系统评价和荟萃分析。
Eur J Radiol. 2019 Jan;110:156-162. doi: 10.1016/j.ejrad.2018.11.034. Epub 2018 Nov 28.
3
Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy.
胃肠外科肿瘤学中的个性化医疗方法:当前趋势与未来展望
J Pers Med. 2025 Apr 27;15(5):175. doi: 10.3390/jpm15050175.
4
A CT-based radiomics nomogram for the preoperative prediction of perineural invasion in pancreatic ductal adenocarcinoma.一种基于CT的影像组学列线图用于术前预测胰腺导管腺癌的神经周围侵犯
Front Oncol. 2025 Mar 4;15:1525835. doi: 10.3389/fonc.2025.1525835. eCollection 2025.
5
Delta-Radiomics Approach Using Contrast-Enhanced and Noncontrast-Enhanced Computed Tomography Images for Predicting Distant Metastasis in Patients With Borderline Resectable Pancreatic Carcinoma.使用对比增强和非对比增强计算机断层扫描图像的Delta放射组学方法预测临界可切除胰腺癌患者的远处转移
Adv Radiat Oncol. 2024 Nov 5;10(1):101669. doi: 10.1016/j.adro.2024.101669. eCollection 2025 Jan.
6
Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer.使用人工智能预测和监测胰腺癌的免疫检查点抑制剂治疗。
Int J Mol Sci. 2024 Nov 9;25(22):12038. doi: 10.3390/ijms252212038.
7
The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography.使用双层光谱计算机断层扫描对可切除性胰腺导管腺癌的淋巴结转移进行术前预测。
Eur Radiol. 2025 May;35(5):2692-2701. doi: 10.1007/s00330-024-11143-2. Epub 2024 Oct 24.
8
Contrast-enhanced CT radiomics combined with multiple machine learning algorithms for preoperative identification of lymph node metastasis in pancreatic ductal adenocarcinoma.对比增强CT影像组学联合多种机器学习算法用于术前鉴别胰腺导管腺癌淋巴结转移
Front Oncol. 2024 Sep 13;14:1342317. doi: 10.3389/fonc.2024.1342317. eCollection 2024.
9
Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review.树突状细胞疫苗联合不可逆电穿孔治疗胰腺癌——一篇叙述性综述
Ann Transl Med. 2024 Aug 1;12(4):77. doi: 10.21037/atm-23-1882. Epub 2024 May 28.
10
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.晚期结直肠癌患者抗血管生成治疗反应的预测:从生物学因素到功能成像
Cancers (Basel). 2024 Mar 30;16(7):1364. doi: 10.3390/cancers16071364.
巨噬细胞移动抑制因子介导非典型抗精神病药物治疗引起的代谢功能障碍。
J Clin Invest. 2018 Nov 1;128(11):4997-5007. doi: 10.1172/JCI93090. Epub 2018 Oct 8.
4
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice.早期生活抗生素驱动的失调导致小鼠疫苗免疫反应失调。
Cell Host Microbe. 2018 May 9;23(5):653-660.e5. doi: 10.1016/j.chom.2018.04.009.
5
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.基于定量 CT 图像分析预测胰腺导管腺癌患者的生存情况。
Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.
6
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.胰十二指肠切除术治疗导管腺癌时切缘受累的预后价值:一项法国前瞻性多中心研究的更新结果。
Ann Surg. 2017 Nov;266(5):787-796. doi: 10.1097/SLA.0000000000002432.
7
8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.《美国癌症联合委员会(AJCC)癌症分期手册》第8版:胰腺癌和肝胆癌
Ann Surg Oncol. 2018 Apr;25(4):845-847. doi: 10.1245/s10434-017-6025-x. Epub 2017 Jul 27.
8
Value of lymph node positivity in treatment planning for early stage pancreatic cancer.淋巴结阳性在早期胰腺癌治疗规划中的价值。
Surgery. 2017 Sep;162(3):557-567. doi: 10.1016/j.surg.2017.05.003. Epub 2017 Jun 27.
9
CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis.CT纹理特征与胰腺导管腺癌的总生存期相关——一项定量分析。
BMC Med Imaging. 2017 Jun 19;17(1):38. doi: 10.1186/s12880-017-0209-5.
10
Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.可切除性胰腺腺癌:CT定量成像生物标志物在预测病理及患者预后中的作用
Eur J Radiol. 2017 May;90:152-158. doi: 10.1016/j.ejrad.2017.02.033. Epub 2017 Feb 22.